Nathan E. Wineinger et al. –
KEY POINTS
Question – What are the prices of top-selling brand-name prescription drugs in the United States, and how have these prices changed in recent years?
Findings – In this economic evaluation of 49 common top-selling brand-name drugs, 78% of the drugs that have been available since 2012 have seen an increase in insurer and out-of-pocket costs by more than 50%, and 44% have more than doubled in price.
Meaning – Prices of brand-name drugs in the United States are likely to continue to increase, which warrants greater price transparency.
Read the full article in JAMA Network Open.
